International Stem Cell (ISCO) FCF Margin (2010 - 2025)

International Stem Cell (ISCO) has reported FCF Margin for 16 consecutive years, with 1.35% the latest figure, recorded in Q4 2025.

• On a quarterly basis, FCF Margin rose 441.0% year-over-year to 1.35% in Q4 2025; TTM through Dec 2025 was 0.38%, a 130.0% increase from a year earlier, with the FY2025 full-year figure at 0.38%, up 130.0% from the prior year.
• FCF Margin was 1.35% for Q4 2025 at International Stem Cell, down from 1.94% in the prior quarter.
• Over five years, FCF Margin peaked at 23.85% in Q2 2023 and troughed at 23.76% in Q1 2021.
• A 5-year average of 0.94% and a median of 1.64% in 2025 frame the typical range for FCF Margin.
• Across the five-year window, FCF Margin plunged 3487 bps in 2021 and jumped 2928 bps in 2022, its largest moves.
• Over 5 years, FCF Margin stood at 17.69% in 2021, then surged by 118 bps to 3.25% in 2022, then jumped by 162 bps to 8.52% in 2023, then plunged by 136 bps to 3.07% in 2024, then jumped by 144 bps to 1.35% in 2025.
• The last three FCF Margin figures came in at 1.35% (Q4 2025), 1.94% (Q3 2025), and 13.57% (Q2 2025), per Business Quant data.